Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

Healthcare Biotechnology
"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

BioExx Specialty Proteins Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by dant2on Dec 11, 2009 1:16am
185 Views
Post# 16576507

RE: RE: Ooops! rljp RE: RE: The $2 curse

RE: RE: Ooops! rljp RE: RE: The $2 curseThe $2 curse may have a lot to do with ongoing insider sales from CEO, CFO & directors, all the way up through the fall and at recent prices. Or maybe they just have too many shares and want to lock in some profits, or maybe they perceive real execution risks associated with Feb expectations - for which they continue to perptuate the notion that everything is on track. Being an outsider its really difficul to tell.
Insider sales are holding me back from taking a position. I wish I had bought before the run up but now I'm thinking I really have to wait for real results in Q1. Congrats to all of you who got in early, you can afford to take the chance.
Dan
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities